✦ LIBER ✦

Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors

✍ Scribed by W. MA; F. GILES; X. ZHANG; X. WANG; Z. ZHANG; T.-S. LEE; C.-H. YEH; M. ALBITAR

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel Bcr-Abl splice isoform is associ

✍ Gruber, F X; Hjorth-Hansen, H; Mikkola, I; Stenke, L; Johansen, T 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 181 KB

Dasatinib Resistance in Patients with Ch

✍ Krijanovski, Yelena; Donato, Nicholas; Sun, Hanshi; Meng, Feng; Quintás-Cardama, 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 105 KB

Constant BCR-ABL transcript level ≥0.1%

✍ Kateřina Machová Poláková; Václava Polívková; Jana Rulcová; Hana Klamová; Tomáš 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 282 KB

Second-line treatment with dasatinib in

✍ Simona Soverini; Giovanni Martinelli; Sabrina Colarossi; Alessandra Gnani; Miche 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 141 KB

The BCR–ABL1 T315I mutation and addition

✍ Malcikova, Jitka; Razga, Filip; Jurcek, Tomas; Dvorakova, Dana; Zackova, Daniela 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 244 KB

A novel I293MP mutation within BCR-ABL k

✍ Pu Kuang; Ting Liu; Qi Huang; Yuanxin Ye; Bing Xiang; Jie Huang; Lei Diwu; Yuchu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 698 KB